PHILADELPHIA, Pa., Feb. 25, 2016 -- Chemtura Corporation (NYSE:CHMT) (EURONEXT:CHMT) today announced that Stephen Forsyth, Executive Vice President and Chief Financial Officer, will attend the Susquehanna’s 2016 Chemical Conference on Tuesday, March 8, 2016. The conference will run from 8:00 a.m. to 4:40 a.m. (EDT) at The Langham Hotel, 250 Franklin Street, in Boston.
The format will consist of one-on-one and small group meetings only.
Chemtura Corporation, with 2015 sales of $1.7 billion, is a global manufacturer and marketer of specialty chemicals. Additional information concerning Chemtura is available at www.chemtura.com.
Matthew Sokol Director, Investor Relations and Corporate Development Tel: (203) 573-2153


Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz
LG Energy Solution Shares Slide After Ford Cancels EV Battery Supply Deal
ANZ New CEO Forgoes Bonus After Shareholders Reject Executive Pay Report
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role
Micron Technology Forecasts Surge in Revenue and Earnings on AI-Driven Memory Demand
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law
Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling
Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
Boeing Seeks FAA Emissions Waiver to Continue 777F Freighter Sales Amid Strong Cargo Demand
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland 



